HC Wainwright & Co. Initiates Coverage On Sophia Genetics with Buy Rating, Announces Price Target of $12

SOPHiA GENETICS SA

SOPHiA GENETICS SA

SOPH

0.00

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Sophia Genetics (NASDAQ: SOPH) with a Buy rating and announces Price Target of $12.